Abstract:Since its initial identification, the Forkhead Box P2 gene ( FOXP2 ) has maintained its singular status as the archetypal monogenic determinant implicated in Mendelian forms of human speech and language impairments. Despite the passage of two decades subsequent to its discovery, extant literature remains disproportionately sparse with regard to case-specific instances and loci of mutational perturbations. The objective of the current investigation centers on furnishing an enriched delineation of both its clinical manifestations and its mutational heterogeneity. Clinical phenotypes and peripheral blood samples were assiduously amassed from familial subjects. Whole-exome sequencing and Sanger sequencing methodologies were deployed for the unambiguous identification of potential genetic variants and for corroborating their co-segregation within the family pedigree. An exhaustive review of published literature focusing on patients manifesting speech and language disorders consequent to FOXP2 genetic anomalies was also undertaken. The investigation yielded the identification of a novel heterozygous variant, c.661del (p.L221Ffs*41), localized within the FOXP2 gene in the proband, an inheritance from his symptomatic mother. The proband presented with an array of symptoms, encompassing dysarthric speech, deficits in instruction comprehension, and communicative impediments. In comparison, the mother exhibited attenuated symptoms, including rudimentary verbalization capabilities punctuated by pronounced stuttering and dysarthria. A comprehensive analysis of articles archived in the Human Gene Mutation Database (HGMD) classified under "DM" disclosed the existence of 74 patients inclusive of the subjects under current examination, sub-divided into 19 patients with null variants, 5 patients with missense variants, and 50 patients with gross deletions or complex genomic rearrangements. A conspicuous predominance of delayed speech, impoverished current verbal abilities, verbal comprehension deficits, and learning difficulties were observed in patients harboring null or missense FOXP2 variants, as compared to their counterparts with gross deletions or complex rearrangements. Developmental delays, hypotonia, and craniofacial aberrations were exclusive to the latter cohort. The elucidated findings augment the existing corpus of knowledge on the genetic architecture influencing both the proband and his mother within this specified familial context. Of critical importance, these discoveries furnish a robust molecular framework conducive to the prenatal diagnostic evaluations of prospective progeny within this familial lineage.

Genetic analyses of a large consanguineous south Indian family reveal novel variants in NAGPA and four hitherto unreported genes in developmental stuttering

De novo protein-coding gene variants in developmental stuttering

Atypical development of Broca's area in a large family with inherited stuttering

IFNAR1 Gene Mutation May Contribute to Developmental Stuttering in the Chinese Population

Association Study of Stuttering Candidate Genes GNPTAB, GNPTG and NAGPA with Dyslexia in Chinese Population

Audiological and Genetic Studies on Large Families with Non-Syndromic Deafness

Genome Sequencing of Idiopathic Speech Delay

Title Stuttering candidate genes DRD 2 but not SLC 6 A 3 is associatedwith developmental dyslexia in Chinese population

Clinical and genetic characterization of patients segregating variants in KPTN, MINPP1, NGLY1, AP4B1, and SON underlying neurodevelopmental disorders: Genetic and phenotypic expansion

Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental dyslexia in Chinese population

Novel FOXP2 variant associated with speech and language dysfunction in a Chinese family and literature review

Genetic architecture of childhood speech disorder: a review

Resolution of SLC6A1 variable expressivity in a multi-generational family using deep clinical phenotyping and Drosophila models

Genetic Heterogeneity in Four Probands Reveals HGSNAT, KDM6B, LMNA and WFS1 Related Neurodevelopmental Disorders

The clinical and genetic spectrum of paediatric speech and language disorders in 52,143 individuals

Innovative Family-Based Genetically Informed Series of Analyses of Whole-Exome Data Supports Likely Inheritance for Grammar in Children with Specific Language Impairment

Heterozygous variants in PRPF8 are associated with neurodevelopmental disorders

Novel Variants of PPP2R1A in Catalytic Subunit Binding Domain and Genotype–Phenotype Analysis in Neurodevelopmentally Delayed Patients

Atypical gut microbiota composition in a mouse model of developmental stuttering

Detection of Chromosomal Breakpoints in Patients with Developmental Delay and Speech Disorders.

Localization of stuttering based on causal brain lesions